In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?

Ronan Swords, Valeria Santini

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

A 75-year-old man visits his primary care physician for a routine checkup and a complete blood count reveals pancytopenia. BM examination confirms the diagnosis of acute myeloid leukemia. No dysplastic features were noted and his karyotype results are pending. The patient has well-controlled hypertension and his last hospital admission was 20 years ago for repair of a rotator cuff injury. His Eastern Cooperative Oncology Group performance status is 0/4 and he has no cognitive impairment. You believe the patient is fit for standard acute myeloid leukemia induction, but you are concerned because of his older age and you are considering less-intensive approaches.

Original languageEnglish (US)
Pages (from-to)74-75
Number of pages2
JournalHematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program
Volume2012
StatePublished - 2012

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'In elderly patients with AML, which patients should be considered fit or unfit for standard induction therapy?'. Together they form a unique fingerprint.

  • Cite this